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cdves. The An of this study was to determine whether left
v
	
dilation and con tine heart failure In patients with
tlc fever with carditis are accompanied by left
vent r etractile dysfunction .
Rscc d Acute rheumatic fever with carditis Involves both
the my lent and end rdium, with consequent vaivular
ref urttarelative contribution of volume overload In-
duced by valy regurgitation and myocardial dysfunction due
to rise tle my rditis to the overall degree of left ventricular
dilation and congestive h failure In t patients is unknown .
#s. To investigate this, we evaluated 32 patients (15
malfemale, mean 14 ± 3 years) with documented active
iris and congestive heart failure . All 32 patients were found to
t Mated mitral regurgitation or combined mitral
and aortic regurgitation. Echocardi phic analysis of left ven-
tricular dimensions and systolic performance was performed
before and after isolated initral or combined mitral and aortic
valve replacement and the results were compared with those in 19
.l subjects match for age, gender and body surface area .
have
Current opinion suggests a putative role for myocarditis in
the pathogenesis of left ventricular dilation and congestive
h failure during active rheumatic carditis (1) . In the more
severe form of the disease, a 'toxic rheumatic myocarditis"
has been incriminated (2) . Although histologic evidence of
myoc itis is present in 32 to 95% of autopsy cases (3),
and was reported in every patient undergoing endomyocar-
dial biopsy during the active phase of the disease, it is not
clear that these features are related to abnormalities of left
ventricular contractile function . It is our experience (4) and
that of others (5) that left ventricular dilation and heart
failure rarely occur in the absence of hemo ynamically
significant mitral regurgitation with or without tccompany-
ing aortic regurgitation . In patients with active rheumatic
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MYOCARDITIS
Results . Both preoperative left ventricular end-diastolic diam-
eter and percent fractional shortening were significantly increased
In patients compared with control subjects, (57 7 vs . 43 3 mm,
p < 0.001, and 38 ± 6% vs . 33 I%, p < 0.001, respectively) .
After valve replacement, left ventricular end-diastolic diameter
decreased significantly (57 7 to 47 6 mm, p < 0 .001) .
Although percent fra tional shortening decreased significantly
postoperatively (38 6% to 32 ± 6%, p < 0 . 1), the postoper-
ative percent fractional shortening did not differ from that in
control subjects (32 ± 6 vs. 33 ± I%, p = NS) .
Conclusions. The results of this study indicate that left ventric-
ular dilation and heart failure in patients with acute rheumatic
lef
itis rarely occur in the absence of hemodynamically signifi-
cant regurgitant valve lesions . Furthermore, rapid reduction in
t ventricular dimensions and preservation of fractional short-
ening after isolated mitral or combined mitral and aortic valve
replacement su t that rheumatic carditis is not accompanied by
any significant degree of myocardial contractile dysfunction .
( Am Coll Cardiol 1993,22.826-9)
carditis presenting with overt heart failure, functionally
severe mitral rerpyitation and its anatomic correlate of
annular dilation, chordal elongation and prolapse of the
anterior mitral leaflet have been observed sufficiently fre-
quently by us (6) to be regarded as a pathoanatomic hallmark
of the disease . To clarify the relative contribution of volume
overload induced by valvular regurgitation and myocardial
dysfunction due to rheumatic myocarditis to the overall
degree of left ventricular dilation, we analyzed left ventric-
ular dimensions and function noninvasively in a group of
young patients with documented active rheumatic carditis
before and after successful isolated mitral or combined
mitral and aortic valve replacement.
Methods
Patient selection . Over a 3-year period, 43 patients with
documented active rheumatic carditis and congestive heart
failure were seen at the Baragwanath Hospital . All 43
patients were found to have hemodynamically compromising
mitral regurgitation with or without aortic regurgitation for
which single- or double-prosthetic valve implantation was
performed. Thirty-two of these patients had preoperative
0735-10971931$6.00
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Table 1 . ' eft Ventricular Internal Dimensions in Systole and Diastole and Fractional Shortening Measured Preoperatively and 3 Months
Postoperatively in Study Group and in Normal Control Subjects
and 3-month postoperative echocardiographic evaluation
data available for analysis and constitute the study group .
The severity of valvular regurgitation was corroborated on
clinical evaluation, chest roentgenograms and Doppler
echocardiographic evaluation and confirmed on intmopera-
five hemodynamic assessment in all patients . Diagnostic
criteria for active rheumatic carditis included the modified
Jones criteria (7), macroscopic appearance of the heart
tissues at the time of surgery (t,9) and light microscopic
features of active carditis (9,10) in tissues submitted for
histologic study . Of the 32 patients who constituted the
study group, 19 underwent mitral valve replacement only
and 13 underwent combined mitral and aortic valve replace-
ment . Nineteen normal subjects matched for age, gender and
body surface area served as the control group .
Data collection . Hospital records were analyzed for all
historical, echocardiographic, roentgenographic and opera-
tive data. Historical data included age, gender, New York
Heart Association functional class and duration of symp-
toms. Body surface area was computed for each patient .
Two-dimensional echocardiography with two-dimensional ,
targeted M-mode echocardiography was performed in all
patients in the left decubitus position immediately before and
3 months after valve replacement. Left ventricular internal
dimensions in diastole and systole were measured in the
parasternal short-axis view at the level of the tips of the
papillary muscles and fractional shortening was calculated .
All studies were performed using a high resolution cardiac
imaging system (Ultraniark 8 ATL) coupled to 2 .5- or 5-MHz
mechanical transducers .
Valve implantation using St . Jude Medical or Medtronic
Hall prostheses was performed using standard cardiopulmo-
nary bypass and surgical techniques . Myocardial preserva-
tion was achieved using cold potassium crystalloid cardio-
plegia, topical hypothermia and low flow systemic hypothermia
uniformly. The submitral apparatus was resected in all pa-
tients . Postoperative management included routine anticoagu-
lation with warfarin sodium and dipyridamole to maintain a
target international normalized ratio of 2 to 2 .5 and standard
rheumatic fever prophylaxis, Diuretic ageqts and angiotensin-
converting enzyme inhibitors were used routinely preopera-
tively and continued in the same dose postoperatively in all
patients .
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EDD - left ventricular endzdinstolic diameter
; ESD = left ventricular end-systolic diameter ; FS = fractional shortening
;
Post, Pre
= after and before,
respectively, isolated mitral or combined mitral/aoific valve replacement .
Statistical analysis . Data are presewed as mean value ±
SD and comparisons made using two-way repeated mea-
sures analysis of variance . Differences were considered
significant at p < 0 .05 .
Results
Baseline clinical characteristics . Thirty-two patients and
19 control subjects were entered into the study . Be i groups
were well matched for age and body surface area (14 ± 3 vs .
14 = 1 .8 years, p = NS, and 1 .2 ± 0.2 vs . 1 .3 -± 0 .2 m2 , p =
NS, respectively) . Of the 32 patients none were > 19 years
old, and 28 (87%) were
c
6 years old. There were 15 male
and 17 female patients . All patients had clinically decompen-
sated heart failure and 16 (50%) pulmonary edema. By
clinical revaluation, 19 (59%) had predominant mitral regur-
gitation and 1' ' 1 1%) severe combined mitral and aortic
regurgitation .
Evidence for rheumatic activity . All 32 patients met the
prerequisite modified Jones criteria for rheumatic fever .
Carditis was ur : ;,,rmly present. Macroscopic features of
active rheumatic carditis, including fibrinous pericarditis,
noninfected verrucous vegetations on the free edge of the
mitral or aortic leaflets and nonspecific signs of acute in&m-
mation, were seen in 27 patients (84%) . Light microsc(pic
examination of surgically resected cardiac tissue showed
diagnostic histologic features of active rheumatic carditis
(Aschoff nodules and fibrinoid necrosis) in 13 (41%) of
patients and a nonspecific polymorphonuclear inflammatory
response in 21 (669) . One or both of the aforementioned
histologic features were documented in every patient . Char-
acteristic abnormalities on two-dimensional echocardiogra-
phy (6), including mitral annular dilation, chordal elongation
and anterior leaflet prolapse, were present in all 32 (1 00) of
the patients .
Left ventricular dimensions and fractional shortening
(Table 1). At baseline, patients in the carditis group had
significantly increased left ventricular end-diastolic diameter
and percent fractional shortening compared with values in
control subjects (57 ± 7 vs . 43 ± 3 mm, p < 0.001 and 38 t
6% vs
. 33 ± 1%, p < 0 .001, respectively) . After valve
replacement, left ventricular end-diastolic diameter de-
creased significantly (57 ± 7 to 47 ± 6 mm, p < 0.001) .
Control
Group
Study Group
Control Group Versus Study
Group (p Value)
Pre Versus Post
(p Value)
Prc Post Pre
Post
EDD (mm) 43±3 57±7
47±6 * 0,001
< 0 .001
< 0 .001
ESD (mm) 29 ± 2 36 ± 6 32 ± 6
* 0 .001 0 .08
< owl
FS (%) 33 ± 1 38 ± 6 32 ± 6 * 0 .001
0 .68
< 10101
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Although percent fractional shortening decreased signifi-
cantly postoperatively (38± 6% to 32 ± 6%, p < 0 .001), the
postoperative value did not differ from that in control
subjects (32 ± 6% vs . 33 ± 1%, p = NS) .
ussion
In patients with acute rheumatic fever and carditis, the
distinction between left venticular dilation and congestive
heart failure arising as a conseouence of contractile dysfunc-
tion due to rheumatic myocarditis or volume overloading
associated with valvular regurgitation has important 011 -nical
implications. This study represents the first clinical evalua-
tion of left ventricular function in a well categorized group of
patients with documented active rheumatic carditis . Two
major findings of this study are that 1) heart failure in this
disease rarely occurs in the absence of hemodynamically
significant vaWwar regurgitant lesions, and 2) prompt reduc-
tion in left ventricular dimensions and preservation of frac-
tional shortening after isolated mitral or combined mitral and
aortic valve replacement provide good evidence that rheu-
matic carditis is not accompanied by myocardial contractile
dysfunction to any significant degree .
The presence of significant regurgitant lesions in every
patient with acute rheumatin fever and heart failure in this
consecutive analysis of 32 patients is consonant with our
previous experience (4) . Furthermore, our documentation of
the mechanism of mitral regurgitation (6) and, more recently,
of aortic regurgitation (11) provides further evidence for the
pivotal role of vaivular regurgitation in this disease .
Because the first episode of rheumatic fever is often
asymptomatic, and severe episodes may represent the cu-
mulative effect of several previous attacks, it is difficult to
determine the duration of valvular regurgitation in our
patients . Nevertheless, the presence of substantial left ven-
tricular dilation would imply subacute or chronic regurgita-
tion. Am et al. (12) showed the inability of left ventric-
ular volumes to discriminate between subacute and chronic
regurgitation . Although the precise duration of regurgitation
may not be certain, on the basis of clinical, echocardio-
ic and intraoperative observations, its severity is un-
questionable . This is underscored by the marked increase in
en"IdiSMstoUbc diameter (57 ± 7 mm), which becomes even
more significant when one considers that the mean body
surface area in this group of patients was only
1.2 ± 0 .2 0. But the most compelling evidence that left
ventricular dilation and heart failure were largely the result
of vaivular regurgitation is the rapid and significant reduction
in heart size after single- or double- the replacement.
CoahvAk function . Fractional shortening is an ejection
phase index of left ventricular performance that is dependent
on contractility, preload and afterload . Preload is increased
in mitral regurgitation, enhancing ejection performance
(13,14) . in subacute or chronic mitral regurgitation, afterload
is usually normal (15). Thus, in mitral regurgitation aug-
mented preload and normal afterload enhance ejection per-
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formance and raise it to the high normal range (16) . Zile et al .
(17) found that a supernormal shortening fraction >32%
usually predicted a good postoperative result . Using a rela-
tively load-independent index of contractility, Wisenbaugh
(18) found an ejection fraction of 0.6 to be predictive of
normal left ventricular contractile function in patients with
chronic severe mitral regurgitation . After mitral vat re re-
placement, most patients experience a decline in ejection
performance ; however, in patients with good contractile
reserve this decline is small and reflects the adverse postop-
erative loading conditions (19) . Both the supernormal pre-
operative fractional shortening and the nonsignificant post-
operative decline in fractional shortening in our patients are
consistent with relatively well preserved contractile func-
tion . Chordal resection during mitral valve survery has been
demonstrated to adversely affect postoperative left ventric-
ular performance (20,21) . Preservation of ejection perfor-
mance, despite chordal resection in all of our patients,
further argues against the presence of any substantial pre-
operative contractile dysfunction . The decline in end-
systolic diameter after valve replacement also suggests that
if there was any increase in afterload after valve replace-
ment, it was not present at follow-up . It would appear
therefore that histologic rheumatic myocarditis, unlike viral
myocarditis, has no functional consequence in terms of
contractile dysfunction .
Therapeutic implications . Documentation of significant
vaivular regurgitation and absence of left ventricular con-
tractile dysfunction has critical therapeutic implications in
patients with acute rheumatic fever and heart failure . In
those who do not respond to inotropic and vasodilator
therapy, restoring mitral or aortic valve competence be-
comes a priority . Despite th .; disadvantages of prosthetic
valve implantation in this young group of patients, it is our
experience (4) and that of others (22) that this treatment may
be lifesaving and has a reasonably low mortality rate (0% to
4%) in experienced centers . Furthermore, the results of this
study suggest that corticosteroids may be inappropriate
therapy for heart failure in this group of patients .
The absence of contractile dysfuction, even during the
phase of fulminant rheumatic carditis, as the results of our
study suggest, argues against any significant long-term con-
tribution to systolic dysfunction that is sometimes seen in
patients with chronic rheumatic heart disease . Using a
load-independent index of left ventricular function, our
observation that a low ejection fraction in patients with
mitral stenosis is related to increased afterload with no
identifiable contractile dysfunction (23) further supports this
conclusion. The left ventricular dysfunction seen in patients
with long-standing severe rheumatic mitral regurgitation is
probably related to chronic volume overload, which is also
seen in patients with nonrheumatic mitral regurgitation .
Summary. The results of this study indicate that the
pathogenetic basis of left ventricular dilation and heart
failure in patient; with acute rheumatic fever is severe
isolated mitral regurgitation or combined mitral and aortic
JACC Voi. 22, No . 3
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regurgitation . Despite the presence of rheumatic myocardi-
tis, left ventricular contractile function is unimpaired . These
data provide a rational basis for aggressive surgical interven-
tion in this group of patients .
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